Innovative oral regenerative therapy leveraging immunoregenerative mechanisms.
$55,000R41FY2025DENIH
Oridivus Llc, Decatur GA
Investigators
Abstract
This supplement will support Oridivus, LLC to participate as part of the I-Corps program, focused on developing our business model canvas to assess the gaps in our approach to the oral wound healing market. During the I-Corps program we will perform over 100 interviews identifying the key stakeholders in the oral wound healing environment including dentists, oral surgeons, periodontists, and otolaryngologists along with the specific user needs of each different speciality. At the conclusion of the I-Corps program we will have identified the beach head market, a plan to address an unmet need in the market and continued to refine our business model canvas based on our ongoing customer and ecosystem discovery.
View original record on NIH RePORTER →